ASET Interviews US CEO, Dr. Rich Vogel

AI is transforming healthcare, and its impact on IONM is a growing topic of discussion. In the Spring 2025 issue of NEURO Currents, ASET – The Neurodiagnostic Society’s quarterly newsletter, Nervio’s US CEO Dr. Rich Vogel was interviewed by the ASET Innovation Committee about the evolving role of AI in IONM.

In the interview, Dr. Vogel discusses how AI is shaping the field—from enhancing clinical decision-making to increasing efficiency in neurodiagnostic workflows. He also addresses common concerns about AI adoption, patient safety, and the future of IONM professionals in an AI-integrated environment.

While the full interview is available exclusively to ASET members, this conversation highlights the broader industry shift toward AI-driven solutions in neurodiagnostics. Nervio remains committed to advancing safe and effective AI applications to support clinicians and improve patient outcomes.

To learn more about ASET and their work in neurodiagnostics, visit www.aset.org.

Stay connected with Nervio for more insights on AI in IONM.